2m 2m 2m 2m 2m 2m 2m
METAVIA (MTVA)
NASDAQ
$1.56+$0.02 (+1.30%)
Price as of Jun 23, 2026 7:52 PM EDT- $8.1MMarket Cap
- -78.70%1-Year Change
- BiotechnologyIndustry
METAVIA (MTVA)
$1.56+$0.02 (+1.30%)
MTVA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $1.54 | ||
Change | -$0.03 (-1.91%) | ||
Open | $1.52 | ||
High | $1.64 | ||
Low | $1.50 | ||
Previous Close | $1.57 | ||
Volume | 517,652 | ||
30-Day Average Volume | 1,770,162 | ||
1-Week Change | -6.67% | ||
1-Month Change | -60.00% | ||
1-Year Change | -79.15% | ||
3-Year Change | N/A | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 5.2M | ||
Total Assets | $14.4M | ||
Market Cap | $8.1M | ||
Enterprise Value | -$5.6M | ||
Period: QTR TTM FY | |||
Revenue | $85,000.00 | ||
Net Income | -$3.8M | ||
Free Cash Flow | -$4.3M | ||
EBIT | -$3.8M | ||
EBITDA | -$3.8M | ||
Net Working Capital | $9.0M | ||
EPS | -$0.79 | ||
Enterprise Value/EBITDA | 1 | ||
Enterprise Value/Revenue | -66 | ||
P/B | 1 | ||
P/E | -2 | ||
PEG | 0 | ||
Price/Free Cash Flow | -2 | ||
Price/Operating Cash Flow | -2 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 11 | ||
Last Split Date | 12/05/2025 | ||
Earnings & Revenue